MINI FUTURE SHORT - BECTON DICKINSON AND CO. Stock

Certificat

DE000MB963N6

Real-time Bid/Ask 03:32:55 2024-05-22 am EDT
8.04 EUR / 8.25 EUR +1.05% Intraday chart for MINI FUTURE SHORT - BECTON DICKINSON AND CO.
Current month-1.83%
1 month-3.36%
Date Price Change
24-05-21 8.06 +2.81%
24-05-20 7.84 -1.26%
24-05-17 7.94 +1.79%
24-05-16 7.8 -0.13%
24-05-15 7.81 -2.98%

Delayed Quote Börse Stuttgart

Last update May 21, 2024 at 03:54 pm EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MB963N
ISINDE000MB963N6
Date issued 2023-07-26
Strike 322 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.85
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.54
Lowest since issue 3.33
Spread 0.21
Spread %2.55%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
234.9 USD
Average target price
279 USD
Spread / Average Target
+18.79%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW